nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0915	0.137	CbGbCtD
Labetalol—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0861	0.129	CbGbCtD
Labetalol—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0861	0.129	CbGbCtD
Labetalol—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0778	0.116	CbGbCtD
Labetalol—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0778	0.116	CbGbCtD
Labetalol—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0672	0.1	CbGbCtD
Labetalol—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0652	0.0974	CbGbCtD
Labetalol—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.059	0.0881	CbGbCtD
Labetalol—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.059	0.0881	CbGbCtD
Labetalol—Mirabegron—ALB—acquired immunodeficiency syndrome	0.000734	0.427	CrCbGaD
Labetalol—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.000438	0.255	CrCbGaD
Labetalol—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00039	0.00119	CcSEcCtD
Labetalol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000389	0.00119	CcSEcCtD
Labetalol—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.00118	CcSEcCtD
Labetalol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000388	0.00118	CcSEcCtD
Labetalol—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00118	CcSEcCtD
Labetalol—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.00118	CcSEcCtD
Labetalol—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000386	0.00117	CcSEcCtD
Labetalol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000384	0.00117	CcSEcCtD
Labetalol—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00117	CcSEcCtD
Labetalol—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00116	CcSEcCtD
Labetalol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000379	0.00115	CcSEcCtD
Labetalol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000378	0.00115	CcSEcCtD
Labetalol—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000378	0.00115	CcSEcCtD
Labetalol—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.00115	CcSEcCtD
Labetalol—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00115	CcSEcCtD
Labetalol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00114	CcSEcCtD
Labetalol—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000375	0.00114	CcSEcCtD
Labetalol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000375	0.00114	CcSEcCtD
Labetalol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000374	0.00114	CcSEcCtD
Labetalol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00114	CcSEcCtD
Labetalol—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000373	0.00113	CcSEcCtD
Labetalol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000372	0.00113	CcSEcCtD
Labetalol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00113	CcSEcCtD
Labetalol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.00113	CcSEcCtD
Labetalol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000371	0.00113	CcSEcCtD
Labetalol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00112	CcSEcCtD
Labetalol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000369	0.00112	CcSEcCtD
Labetalol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00112	CcSEcCtD
Labetalol—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00112	CcSEcCtD
Labetalol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00112	CcSEcCtD
Labetalol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00112	CcSEcCtD
Labetalol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000366	0.00111	CcSEcCtD
Labetalol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000366	0.00111	CcSEcCtD
Labetalol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000366	0.00111	CcSEcCtD
Labetalol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000366	0.00111	CcSEcCtD
Labetalol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000364	0.00111	CcSEcCtD
Labetalol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000363	0.00111	CcSEcCtD
Labetalol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000363	0.0011	CcSEcCtD
Labetalol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.0011	CcSEcCtD
Labetalol—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.0011	CcSEcCtD
Labetalol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000362	0.0011	CcSEcCtD
Labetalol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000362	0.0011	CcSEcCtD
Labetalol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.0011	CcSEcCtD
Labetalol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.0011	CcSEcCtD
Labetalol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00036	0.0011	CcSEcCtD
Labetalol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.0011	CcSEcCtD
Labetalol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00109	CcSEcCtD
Labetalol—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000359	0.00109	CcSEcCtD
Labetalol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000358	0.00109	CcSEcCtD
Labetalol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00109	CcSEcCtD
Labetalol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000357	0.00109	CcSEcCtD
Labetalol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00109	CcSEcCtD
Labetalol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000356	0.00108	CcSEcCtD
Labetalol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00108	CcSEcCtD
Labetalol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.00108	CcSEcCtD
Labetalol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00107	CcSEcCtD
Labetalol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00107	CcSEcCtD
Labetalol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00107	CcSEcCtD
Labetalol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00107	CcSEcCtD
Labetalol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.00107	CcSEcCtD
Labetalol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00106	CcSEcCtD
Labetalol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00106	CcSEcCtD
Labetalol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00106	CcSEcCtD
Labetalol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000347	0.00106	CcSEcCtD
Labetalol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.00105	CcSEcCtD
Labetalol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.00105	CcSEcCtD
Labetalol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000346	0.00105	CcSEcCtD
Labetalol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00105	CcSEcCtD
Labetalol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.00105	CcSEcCtD
Labetalol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000345	0.00105	CcSEcCtD
Labetalol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000345	0.00105	CcSEcCtD
Labetalol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.00105	CcSEcCtD
Labetalol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.00105	CcSEcCtD
Labetalol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.00105	CcSEcCtD
Labetalol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00105	CcSEcCtD
Labetalol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00104	CcSEcCtD
Labetalol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.00104	CcSEcCtD
Labetalol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00104	CcSEcCtD
Labetalol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00034	0.00103	CcSEcCtD
Labetalol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.00103	CcSEcCtD
Labetalol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00103	CcSEcCtD
Labetalol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00102	CcSEcCtD
Labetalol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00102	CcSEcCtD
Labetalol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00102	CcSEcCtD
Labetalol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000334	0.00102	CcSEcCtD
Labetalol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000333	0.00101	CcSEcCtD
Labetalol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000333	0.00101	CcSEcCtD
Labetalol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000332	0.00101	CcSEcCtD
Labetalol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00101	CcSEcCtD
Labetalol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00101	CcSEcCtD
Labetalol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.00101	CcSEcCtD
Labetalol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.001	CcSEcCtD
Labetalol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.001	CcSEcCtD
Labetalol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.001	CcSEcCtD
Labetalol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.001	CcSEcCtD
Labetalol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.001	CcSEcCtD
Labetalol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.000999	CcSEcCtD
Labetalol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000328	0.000999	CcSEcCtD
Labetalol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.000998	CcSEcCtD
Labetalol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000327	0.000996	CcSEcCtD
Labetalol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000327	0.000995	CcSEcCtD
Labetalol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.000987	CcSEcCtD
Labetalol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000324	0.000985	CcSEcCtD
Labetalol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.000981	CcSEcCtD
Labetalol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.000981	CcSEcCtD
Labetalol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00098	CcSEcCtD
Labetalol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00098	CcSEcCtD
Labetalol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.000978	CcSEcCtD
Labetalol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00032	0.000975	CcSEcCtD
Labetalol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000319	0.00097	CcSEcCtD
Labetalol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.000969	CcSEcCtD
Labetalol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.000969	CcSEcCtD
Labetalol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000318	0.000967	CcSEcCtD
Labetalol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.000966	CcSEcCtD
Labetalol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000317	0.000966	CcSEcCtD
Labetalol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000965	CcSEcCtD
Labetalol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.000964	CcSEcCtD
Labetalol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000317	0.000964	CcSEcCtD
Labetalol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000316	0.000961	CcSEcCtD
Labetalol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000316	0.000961	CcSEcCtD
Labetalol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00096	CcSEcCtD
Labetalol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000315	0.000958	CcSEcCtD
Labetalol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000315	0.000958	CcSEcCtD
Labetalol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.000958	CcSEcCtD
Labetalol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000314	0.000957	CcSEcCtD
Labetalol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000313	0.000953	CcSEcCtD
Labetalol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000313	0.000952	CcSEcCtD
Labetalol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.000952	CcSEcCtD
Labetalol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.000952	CcSEcCtD
Labetalol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000311	0.000947	CcSEcCtD
Labetalol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00031	0.000944	CcSEcCtD
Labetalol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.000943	CcSEcCtD
Labetalol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.000936	CcSEcCtD
Labetalol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.000932	CcSEcCtD
Labetalol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.000931	CcSEcCtD
Labetalol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.000931	CcSEcCtD
Labetalol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.000926	CcSEcCtD
Labetalol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.000926	CcSEcCtD
Labetalol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000924	CcSEcCtD
Labetalol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.000924	CcSEcCtD
Labetalol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.000921	CcSEcCtD
Labetalol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00092	CcSEcCtD
Labetalol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000917	CcSEcCtD
Labetalol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0003	0.000914	CcSEcCtD
Labetalol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0003	0.000913	CcSEcCtD
Labetalol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.000912	CcSEcCtD
Labetalol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.000912	CcSEcCtD
Labetalol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000299	0.000911	CcSEcCtD
Labetalol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000295	0.000898	CcSEcCtD
Labetalol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.000896	CcSEcCtD
Labetalol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.000894	CcSEcCtD
Labetalol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00089	CcSEcCtD
Labetalol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000292	0.00089	CcSEcCtD
Labetalol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.000889	CcSEcCtD
Labetalol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.000889	CcSEcCtD
Labetalol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.000887	CcSEcCtD
Labetalol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.000886	CcSEcCtD
Labetalol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.000886	CcSEcCtD
Labetalol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.000886	CcSEcCtD
Labetalol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.000886	CcSEcCtD
Labetalol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.000882	CcSEcCtD
Labetalol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.000878	CcSEcCtD
Labetalol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000288	0.000877	CcSEcCtD
Labetalol—Flurbiprofen—ALB—acquired immunodeficiency syndrome	0.000286	0.167	CrCbGaD
Labetalol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.000863	CcSEcCtD
Labetalol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00086	CcSEcCtD
Labetalol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.000855	CcSEcCtD
Labetalol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000854	CcSEcCtD
Labetalol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.000853	CcSEcCtD
Labetalol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.000853	CcSEcCtD
Labetalol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000848	CcSEcCtD
Labetalol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000279	0.000848	CcSEcCtD
Labetalol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.000848	CcSEcCtD
Labetalol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.000848	CcSEcCtD
Labetalol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.000846	CcSEcCtD
Labetalol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.000841	CcSEcCtD
Labetalol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00084	CcSEcCtD
Labetalol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00084	CcSEcCtD
Labetalol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.000838	CcSEcCtD
Labetalol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.000835	CcSEcCtD
Labetalol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.000829	CcSEcCtD
Labetalol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.000826	CcSEcCtD
Labetalol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.000823	CcSEcCtD
Labetalol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000822	CcSEcCtD
Labetalol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.000821	CcSEcCtD
Labetalol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00082	CcSEcCtD
Labetalol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.000819	CcSEcCtD
Labetalol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.000819	CcSEcCtD
Labetalol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.000816	CcSEcCtD
Labetalol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.000814	CcSEcCtD
Labetalol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.000814	CcSEcCtD
Labetalol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000804	CcSEcCtD
Labetalol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.000802	CcSEcCtD
Labetalol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.000793	CcSEcCtD
Labetalol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000793	CcSEcCtD
Labetalol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00026	0.000792	CcSEcCtD
Labetalol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000789	CcSEcCtD
Labetalol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000789	CcSEcCtD
Labetalol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000259	0.000788	CcSEcCtD
Labetalol—Ketoprofen—ALB—acquired immunodeficiency syndrome	0.000259	0.151	CrCbGaD
Labetalol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000784	CcSEcCtD
Labetalol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000257	0.000782	CcSEcCtD
Labetalol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000257	0.000781	CcSEcCtD
Labetalol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.000778	CcSEcCtD
Labetalol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000255	0.000777	CcSEcCtD
Labetalol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000775	CcSEcCtD
Labetalol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000767	CcSEcCtD
Labetalol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.000764	CcSEcCtD
Labetalol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000756	CcSEcCtD
Labetalol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000752	CcSEcCtD
Labetalol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000752	CcSEcCtD
Labetalol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.000745	CcSEcCtD
Labetalol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.000744	CcSEcCtD
Labetalol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000741	CcSEcCtD
Labetalol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000739	CcSEcCtD
Labetalol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.000738	CcSEcCtD
Labetalol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000242	0.000736	CcSEcCtD
Labetalol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000735	CcSEcCtD
Labetalol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.000734	CcSEcCtD
Labetalol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000733	CcSEcCtD
Labetalol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000716	CcSEcCtD
Labetalol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000713	CcSEcCtD
Labetalol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000709	CcSEcCtD
Labetalol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000707	CcSEcCtD
Labetalol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000706	CcSEcCtD
Labetalol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000706	CcSEcCtD
Labetalol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.000702	CcSEcCtD
Labetalol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000701	CcSEcCtD
Labetalol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.000696	CcSEcCtD
Labetalol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000685	CcSEcCtD
Labetalol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000683	CcSEcCtD
Labetalol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000683	CcSEcCtD
Labetalol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000673	CcSEcCtD
Labetalol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.000666	CcSEcCtD
Labetalol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00066	CcSEcCtD
Labetalol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000659	CcSEcCtD
Labetalol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000654	CcSEcCtD
Labetalol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000653	CcSEcCtD
Labetalol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000651	CcSEcCtD
Labetalol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000649	CcSEcCtD
Labetalol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000634	CcSEcCtD
Labetalol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000629	CcSEcCtD
Labetalol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000629	CcSEcCtD
Labetalol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000628	CcSEcCtD
Labetalol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000625	CcSEcCtD
Labetalol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000616	CcSEcCtD
Labetalol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000605	CcSEcCtD
Labetalol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.0006	CcSEcCtD
Labetalol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.0006	CcSEcCtD
Labetalol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000596	CcSEcCtD
Labetalol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000593	CcSEcCtD
Labetalol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000565	CcSEcCtD
